News
10h
News-Medical.Net on MSNSemaglutide clears liver inflammation and cuts fibrosis in MASH patients, trial showsA phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
Results showed that 62.9% of patients on Ozempic saw a reduction in liver inflammation, compared to 34.3% on placebo.
3d
New Scientist on MSNDrugs like Wegovy can be effective at treating fatty liver diseaseSemaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results